Wiley Bros. Aintree Capital, LLC Insmed Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $2.26 Billion
- Q2 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Insmed Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 4,477 shares of INSM stock, worth $320,956. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,477Holding current value
$320,956% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding INSM
# of Institutions
455Shares Held
173MCall Options Held
5.75MPut Options Held
5.11M-
Vanguard Group Inc Valley Forge, PA16MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.02 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$872 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA5.87MShares$421 Million0.08% of portfolio
-
State Street Corp Boston, MA4.66MShares$334 Million0.01% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.71B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...